This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inaba, T.
Right arrow Articles by Yamada, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inaba, T.
Right arrow Articles by Yamada, N.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 05 1996, 2264-2273, Vol 16, No. 5
Copyright © 1996, American Society for Microbiology

Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells

T Inaba, T Gotoda, S Ishibashi, K Harada, JI Ohsuga, K Ohashi, Y Yazaki and N Yamada
3rd Department of Internal Medicine, University of Tokyo, Japan.

The macrophage colony-stimulating factor receptor encoded by the c-fms gene is expressed in vascular intimal smooth muscle cells isolated from atherosclerotic lesions. A combination of platelet-derived growth factor-BB and epidermal growth factor induces stable expression of c- fms in normal vascular medial smooth muscle cells. The mechanism by which these growth factors induce c-fms expression has now been investigated in an attempt to gain insight into the events that underlie the phenotypic conversion of vascular smooth muscle cells in atherosclerosis. Deletion analysis of the c-fms promoter revealed that the region including a binding site for transcription factor PU.1 was required for transcriptional activity in human aortic medial smooth muscle cells. Mutation in the PU.1 binding site markedly reduced promoter activity. Northern (RNA) blot analysis demonstrated that growth factors induced the expression of PU.1 mRNA in vascular medial smooth muscle cells and that PU.1 mRNA was expressed in vascular intimal smooth muscle cells. PU.1 antisense oligonucleotides inhibited growth factor-induced c-fms expression and foam cell formation. These results suggest that transcription factor PU.1 plays an essential role in the phenotypic conversion of vascular smooth muscle cells to macrophagelike cells by mediating the induction of c-fms.


This article has been cited by other articles:

  • Forrest, S., McNamara, C. (2004). Id Family of Transcription Factors and Vascular Lesion Formation. Arterioscler. Thromb. Vasc. Bio. 24: 2014-2020 [Abstract] [Full Text]  
  • Owens, G. K., Kumar, M. S., Wamhoff, B. R. (2004). Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease. Physiol. Rev. 84: 767-801 [Abstract] [Full Text]  
  • Johnson, A. D., Owens, G. K. (1999). Differential activation of the SMalpha A promoter in smooth vs. skeletal muscle cells by bHLH factors. Am. J. Physiol. Cell Physiol. 276: C1420-C1431 [Abstract] [Full Text]  
  • Perkel, J. M., Atchison, M. L. (1998). A Two-Step Mechanism for Recruitment of Pip by PU.1. J. Immunol. 160: 241-252 [Abstract] [Full Text]  
  • Newberry, E. P., Willis, D., Latifi, T., Boudreaux, J. M., Towler, D. A. (1997). Fibroblast Growth Factor Receptor Signaling Activates the Human Interstitial Collagenase Promoter via the Bipartite Ets-AP1 Element. Mol. Endocrinol. 11: 1129-1144 [Abstract] [Full Text]  
  • Rieske, P., Pongubala, J. M. R. (2001). AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain. J. Biol. Chem. 276: 8460-8468 [Abstract] [Full Text]